EPE111 | 'We are equal': increasing service uptake through strategic communications | E-poster | Strategies to enhance U=U communication and implementation |
EPD132 | We decide for ourselves! Community feedback on transgender persons (protection of rights) rules 2020: implications for social determinants of health and HIV | E-poster | Transgender people |
EPE364 | 'We should have access to information at our fingertips' ' results of a mixed methods study of data availability and use by decision makers for HIV programs in Blantyre, Malawi | E-poster | Approaches to using data to improve programming |
OALBX0105 | Week 48 results of a Phase 3 randomized controlled trial of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) vs dolutegravir + emtricitabine/tenofovir Disoproxil Fumarate (DTG+F/TDF) as initial treatment in HIV/HBV-coinfected adults (ALLIANCE) | Oral abstract session with live Q&A | Viral hepatitis C and other viral hepatitis (e.g., A, B, D, E) |
EPB183 | Week 96 weight and lipid changes from baseline among participants receiving cabotegravir and rilpivirine long-acting or comparator therapy in the ATLAS-2M and FLAIR studies | E-poster | Long-acting agents and other drug delivery systems (e.g., injectables, implants, dual therapies, microneedle patches) |
EPB114 | Weight change when discontinuing integrase strand transfer inhibitors in people living with HIV | E-poster | Weight gain |
EPB119 | Weight changes and pregnancy outcomes among pregnant people living with HIV in use of integrase inhibitors initiated before or after conception: a cohort study | E-poster | Weight gain |
EPB110 | Weight gain after antiretroviral therapy initiation in people living with HIV | E-poster | Weight gain |
EPB115 | Weight gain after non-nucleoside reverse transcriptase-to-integrase inhibitor switch in the United States | E-poster | Weight gain |
PESUE19 | What are the 12-month retention and viral suppression outcomes for South African ART clients enrolled in DSD models compared to conventional care? | Poster exhibition | Differentiated service delivery for HIV testing, prevention and treatment |